FDA Approves Change in Storage Conditions for Humate-P The U.S.
FDA Approves Change in Storage Conditions for Humate-P
The U.S. Food and Drug Administration today approved a change in the storage conditions for Humate-P, a treatment for bleeding in certain patients with hemophilia A or von Willebrand Disease (vWD).